Tisdag 26 November | 05:40:20 Europe / Stockholm
Svenska | English

Neodynamics

Bifogade filer

Kursutveckling under dagen för detta pressmeddelande (SEK).

Likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Tid*
2025-02-17 09:00 Bokslutskommuniké 2024
2024-11-19 - Kvartalsrapport 2024-Q3
2024-08-20 - Kvartalsrapport 2024-Q2
2024-07-31 - 15-6 2024
2024-05-23 - X-dag ordinarie utdelning NEOD 0.00 SEK
2024-05-22 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-16 - Bokslutskommuniké 2023
2024-02-16 - Split NEOD 100:1
2024-02-02 - Extra Bolagsstämma 2024
2023-11-27 - Kvartalsrapport 2023-Q3
2023-08-19 - Kvartalsrapport 2023-Q2
2023-07-27 - Extra Bolagsstämma 2023
2023-05-24 - X-dag ordinarie utdelning NEOD 0.00 SEK
2023-05-23 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-17 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning NEOD 0.00 SEK
2022-05-19 - Årsstämma
2022-05-12 - Kvartalsrapport 2022-Q1
2022-02-25 - Extra Bolagsstämma 2022
2022-02-16 - Bokslutskommuniké 2021
2021-11-17 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2
2021-05-27 - X-dag ordinarie utdelning NEOD 0.00 SEK
2021-05-26 - Årsstämma
2021-05-26 - Kvartalsrapport 2021-Q1
2021-02-17 - Bokslutskommuniké 2020
2020-11-19 - Extra Bolagsstämma 2020
2020-11-19 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-29 - X-dag ordinarie utdelning NEOD 0.00 SEK
2020-05-28 - Årsstämma
2020-05-26 - Kvartalsrapport 2020-Q1
2020-02-05 - Bokslutskommuniké 2019
2020-01-28 - Extra Bolagsstämma 2019
2019-11-21 - Kvartalsrapport 2019-Q3
2019-08-28 - Kvartalsrapport 2019-Q2
2019-05-24 - X-dag ordinarie utdelning NEOD 0.00 SEK
2019-05-23 - Årsstämma
2019-05-21 - Kvartalsrapport 2019-Q1
2019-02-21 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Neodynamics är verksamt inom medicinteknik. Idag är verksamheten inriktad mot att utveckla och kommersialisera produkter för behandling av kritiska sjukdomar. Via egenutvecklad mikropulsteknologi erbjuder bolaget precisionsbehandlingar mot bland annat cancer. Lösningarna används främst vid behandling avb bröstcancer hos kvinnor. Huvudkontoret ligger i Lidingö.
Unofficial trading through Pareto Securities after delisting
2024-07-12 08:59:00

Pareto Securities will hold OTC (unofficial) trading in NeoDynamics' stock after the company is delisted from trading on Nasdaq First North on July 30, 2024.

The assignment includes publishing buy and sell price indications on Pareto's website and on Bloomberg, facilitating trading in the share and closing trades made through Pareto's services.

Pareto provides the opportunity to trade shares online via their website, as well as manually via brokers. They note that trading in unlisted shares can involve a higher risk both through a smaller supply of information and liquidity. Unlisted shares cannot be stored in ISK, but normal custody accounts are fine. For more information regarding price when trading in unlisted shares, Pareto refers to its price list.

For more information, see the Pareto Securities webpage: Trading in unlisted shares, or contact Joakim Appeltofft via joakim.appeltofft@paretosec.com.

About NeoNavia
NeoNavia is a modern biopsy system with a completely new patented pulse technology intended for ultrasound-guided tissue sampling. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumor whilst enabling high-quality tissue samples from both breasts and lymph nodes. The pulse biopsy system NeoNavia is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment.

About NeoDynamics
NeoDynamics AB is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound-guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at leading clinics in Europe and launches in USA during 2024. NeoDynamic’s shares are listed on Nasdaq First North Growth Market Stockholm (ticker: NEOD). The company’s Certified Adviser is Redeye AB.

Attachments
Unofficial trading through Pareto Securities after delisting

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden